Alan R. SHAW

机构：Dana-Farber Cancer Institute · ORCID：0000-0001-6856-6033

发表论文 125 篇 · 总被引 11064 次 · h-index 52

代表论文

• DNA Origami Delivery System for Cancer Therapy with Tunable Release Properties (2012 · ACS Nano · 被引 532)
• Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults (2011 · Vaccine · 被引 296)
• Spatial control of membrane receptor function using ligand nanocalipers (2014 · Nature Methods · 被引 277)
• Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies (2019 · Nature Nanotechnology · 被引 214)
• Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants (2004 · The Journal of Pediatrics · 被引 165)
• Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI) (2011 · Vaccine · 被引 161)